<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181214041960N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-12-12</date_registration>
      <primary_sponsor>Neyshabour University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effects of virtual reality with a vibrator combined with cold on pain, anxiety, and fear caused by venipuncture</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effect of virtual reality with a vibrator combined with cold on pain, anxiety, and fear caused by venipuncture children</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>177</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87245</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, non-probability and convenience sampling will be used in such a way that samples that meet the inclusion criteria will be included in the study. To randomly assign the sample to three groups (Group A, Group B, Group C), the permutation block allocation method will be used. In this study, blocks will be created in 3 pieces. First, all the states are determined.
1.ABC 2. ACB 3.BAC 4.BCA 5.CAB 6.CBA
Then, using the software to determine the permutation blocks, the desired blocks are created from the above 6 blocks using permutation sampling. Finally, 59 blocks of 3 were created, which are presented in a separate file attached to the proposal. In this process, 177 children are examined. In each block, there are three groups A, B, and C, Blinding description: When the child leaves the venipuncture room, the questionnaires are completed by a research associate who is unaware of the type of intervention performed on the child during venipuncture.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Intravenous line placement.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: In the virtual reality group, before the child enters the venipuncture room, headphones and virtual reality glasses are placed on the child's face. The child enters the venipuncture room while watching their favorite animation, and the glasses will remain on the child's face until the end of the procedure. Intervention 2: Intervention group 2: In the local cold with vibration group, the venipuncture procedure is performed by the responsible nurse 30 to 60 seconds before the start of the venipuncture, 3-5 cm above the venipuncture site, a doll garrote that produces vibration (vibration is performed by a vibration motor placed inside the doll's body). An ice bag is attached to the bottom of it and remains in place until the end of the venipuncture. At the end of each venipuncture, the device is disinfected with a 70% alcohol solution and stored in the ward refrigerator (the ice storage part is separated from the vibrator motor). Intervention 3: Control group: In the control group, no intervention other than routine care is provided.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Avijgan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>End of Moqavemat Islami Boulevard, Andisheh Town.</address>
        <city>Neyshabur</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8765432178</zip>
        <telephone>+98 51 4465 9373</telephone>
        <email>avijgan.s@gmail.com</email>
        <affiliation>Neyshabour University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Avijgan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>End of Moqavemat Islami Boulevard, Andisheh Town.</address>
        <city>Neyshabur</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9657686534</zip>
        <telephone>+98 51 4465 9373</telephone>
        <email>Avijgan.s@gmail.com</email>
        <affiliation>Neyshabour University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Need for intravenous line
Willingness of parents and child to participate in the study</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diagnosed cognitive and mental disorders, hearing and vision
The child's condition is urgent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: In the virtual reality group, before the child enters the venipuncture room, headphones and virtual reality glasses are placed on the child's face. The child enters the venipuncture room while watching their favorite animation, and the glasses will remain on the child's face until the end of the procedure.</i_keyword>
      <i_keyword>Intervention group 2: In the local cold with vibration group, the venipuncture procedure is performed by the responsible nurse 30 to 60 seconds before the start of the venipuncture, 3-5 cm above the venipuncture site, a doll garrote that produces vibration (vibration is performed by a vibration motor placed inside the doll's body). An ice bag is attached to the bottom of it and remains in place until the end of the venipuncture. At the end of each venipuncture, the device is disinfected with a 70% alcohol solution and stored in the ward refrigerator (the ice storage part is separated from the vibrator motor).</i_keyword>
      <i_keyword>Control group: In the control group, no intervention other than routine care is provided.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before entering the venipuncture room, immediately after leaving the venipuncture room, and 5 minutes after completion of venipuncture. Method of measurement: Usher Standard Pain Assessment Tool.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: Before entering the venipuncture room, immediately after leaving the venipuncture room, and 5 minutes after completion of venipuncture. Method of measurement: Observational Scale of Behavioral Distress- Revised.</prim_outcome>
      <prim_outcome>Fear. Timepoint: Before entering the venipuncture room, immediately after leaving the venipuncture room, and 5 minutes after completion of venipuncture. Method of measurement: Children's Fear Scale (CFS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pulse. Timepoint: Immediately after completion of venipuncture. Method of measurement: Counting pulse.</sec_outcome>
      <sec_outcome>Breathing. Timepoint: Immediately after completion of venipuncture. Method of measurement: Breath counting.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Neyshabour University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-20</approval_date>
        <contact_name>Ethics Committee of Neyshabur University of Medical Sciences</contact_name>
        <contact_address>Neyshabur University of Medical Sciences, End of Eslami Moqavemat Boulevard, Andisheh Town, Neyshabur Neyshabur Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
